119 related articles for article (PubMed ID: 25486447)
1. Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.
Naik M; Raichurkar A; Bandodkar BS; Varun BV; Bhat S; Kalkhambkar R; Murugan K; Menon R; Bhat J; Paul B; Iyer H; Hussein S; Tucker JA; Vogtherr M; Embrey KJ; McMiken H; Prasad S; Gill A; Ugarkar BG; Venkatraman J; Read J; Panda M
J Med Chem; 2015 Jan; 58(2):753-66. PubMed ID: 25486447
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
Alexandrova LA; Chekhov VO; Shmalenyuk ER; Kochetkov SN; El-Asrar RA; Herdewijn P
Bioorg Med Chem; 2015 Nov; 23(22):7131-7. PubMed ID: 26482569
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening.
Jean Kumar VU; Poyraz Ö; Saxena S; Schnell R; Yogeeswari P; Schneider G; Sriram D
Bioorg Med Chem Lett; 2013 Mar; 23(5):1182-6. PubMed ID: 23391589
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
Jeankumar VU; Alokam R; Sridevi JP; Suryadevara P; Matikonda SS; Peddi S; Sahithi S; Alvala M; Yogeeswari P; Sriram D
Chem Biol Drug Des; 2014 Apr; 83(4):498-506. PubMed ID: 24636345
[TBL] [Abstract][Full Text] [Related]
5. Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue.
Parchina A; Froeyen M; Margamuljana L; Rozenski J; De Jonghe S; Briers Y; Lavigne R; Herdewijn P; Lescrinier E
ChemMedChem; 2013 Aug; 8(8):1373-83. PubMed ID: 23836539
[TBL] [Abstract][Full Text] [Related]
6. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
Venkatraman J; Bhat J; Solapure SM; Sandesh J; Sarkar D; Aishwarya S; Mukherjee K; Datta S; Malolanarasimhan K; Bandodkar B; Das KS
J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a new Mycobacterium tuberculosis thymidylate synthase X inhibitor with a unique inhibition profile.
Abu El Asrar R; Margamuljana L; Klaassen H; Nijs M; Marchand A; Chaltin P; Myllykallio H; Becker HF; De Jonghe S; Herdewijn P; Lescrinier E
Biochem Pharmacol; 2017 Jul; 135():69-78. PubMed ID: 28359706
[TBL] [Abstract][Full Text] [Related]
8. Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase.
Luciani R; Saxena P; Surade S; Santucci M; Venturelli A; Borsari C; Marverti G; Ponterini G; Ferrari S; Blundell TL; Costi MP
J Med Chem; 2016 Oct; 59(19):9269-9275. PubMed ID: 27589670
[TBL] [Abstract][Full Text] [Related]
9. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Structure-Activity Relationship Studies of Benzo[b][1,4]oxazin-3(4H)-one Analogues as Inhibitors of Mycobacterial Thymidylate Synthase X.
Modranka J; Li J; Parchina A; Vanmeert M; Dumbre S; Salman M; Myllykallio H; Becker HF; Vanhoutte R; Margamuljana L; Nguyen H; Abu El-Asrar R; Rozenski J; Herdewijn P; De Jonghe S; Lescrinier E
ChemMedChem; 2019 Mar; 14(6):645-662. PubMed ID: 30702807
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
12. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
13. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 5-substituted 2'-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis.
Kögler M; Vanderhoydonck B; De Jonghe S; Rozenski J; Van Belle K; Herman J; Louat T; Parchina A; Sibley C; Lescrinier E; Herdewijn P
J Med Chem; 2011 Jul; 54(13):4847-62. PubMed ID: 21657202
[TBL] [Abstract][Full Text] [Related]
16. Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors.
Saxena S; Samala G; Sridevi JP; Devi PB; Yogeeswari P; Sriram D
Eur J Med Chem; 2015 Mar; 92():401-14. PubMed ID: 25585006
[TBL] [Abstract][Full Text] [Related]
17. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
18. Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation.
Choi JY; Plummer MS; Starr J; Desbonnet CR; Soutter H; Chang J; Miller JR; Dillman K; Miller AA; Roush WR
J Med Chem; 2012 Jan; 55(2):852-70. PubMed ID: 22243413
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis.
Kögler M; Busson R; De Jonghe S; Rozenski J; Van Belle K; Louat T; Munier-Lehmann H; Herdewijn P
Chem Biodivers; 2012 Mar; 9(3):536-56. PubMed ID: 22422522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
